Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking.

Scott IC, Seegobin SD, Steer S, Tan R, Forabosco P, Hinks A, Eyre S, Morgan AW, Wilson AG, Hocking LJ, Wordsworth P, Barton A, Worthington J, Cope AP, Lewis CM.

PLoS Genet. 2013;9(9):e1003808. doi: 10.1371/journal.pgen.1003808. Epub 2013 Sep 19. Erratum in: PLoS Genet. 2013 Oct;9(10). doi:10.1371/annotation/a86ab397-f58c-4144-a241-4957836a728a.

2.

Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibody-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA).

Too CL, Yahya A, Murad S, Dhaliwal JS, Larsson PT, Muhamad NA, Abdullah NA, Mustafa AN, Klareskog L, Alfredsson L, Padyukov L, Bengtsson C; MyEIRA study group.

Arthritis Res Ther. 2012 Apr 26;14(2):R89. doi: 10.1186/ar3813.

3.

Interaction of HLA-DRB1*09:01 and *04:05 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope.

Bang SY, Lee HS, Lee KW, Bae SC.

J Rheumatol. 2013 Jul;40(7):1054-62. doi: 10.3899/jrheum.121280. Epub 2013 May 1.

PMID:
23637323
4.

Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.

Jiang X, Trouw LA, van Wesemael TJ, Shi J, Bengtsson C, Källberg H, Malmström V, Israelsson L, Hreggvidsdottir H, Verduijn W, Klareskog L, Alfredsson L, Huizinga TW, Toes RE, Lundberg K, van der Woude D.

Ann Rheum Dis. 2014 Oct;73(10):1761-8. doi: 10.1136/annrheumdis-2013-205109. Epub 2014 May 8.

PMID:
24812286
5.

An Immunochip-based interaction study of contrasting interaction effects with smoking in ACPA-positive versus ACPA-negative rheumatoid arthritis.

Jiang X, Källberg H, Chen Z, Ärlestig L, Rantapää-Dahlqvist S, Davila S, Klareskog L, Padyukov L, Alfredsson L.

Rheumatology (Oxford). 2016 Jan;55(1):149-55. doi: 10.1093/rheumatology/kev285. Epub 2015 Aug 13.

PMID:
26272072
6.

Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease.

Fisher BA, Bang SY, Chowdhury M, Lee HS, Kim JH, Charles P, Venables P, Bae SC.

Ann Rheum Dis. 2014 Apr;73(4):741-7. doi: 10.1136/annrheumdis-2012-202535. Epub 2013 Mar 16.

PMID:
23505239
7.

Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.

Lundström E, Källberg H, Smolnikova M, Ding B, Rönnelid J, Alfredsson L, Klareskog L, Padyukov L.

Arthritis Rheum. 2009 Apr;60(4):924-30. doi: 10.1002/art.24410.

8.
9.

Particular association of clinical and genetic features with autoimmunity to citrullinated α-enolase in rheumatoid arthritis.

Montes A, Dieguez-Gonzalez R, Perez-Pampin E, Calaza M, Mera-Varela A, Gomez-Reino JJ, Gonzalez A.

Arthritis Rheum. 2011 Mar;63(3):654-61. doi: 10.1002/art.30186. Erratum in: Arthritis Rheum. 2011 Apr;63(4):938.

10.

Association of environmental and genetic factors and gene-environment interactions with risk of developing rheumatoid arthritis.

Karlson EW, Ding B, Keenan BT, Liao K, Costenbader KH, Klareskog L, Alfredsson L, Chibnik LB.

Arthritis Care Res (Hoboken). 2013 Jul;65(7):1147-56. doi: 10.1002/acr.22005.

11.

Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important.

Lundström E, Källberg H, Alfredsson L, Klareskog L, Padyukov L.

Arthritis Rheum. 2009 Jun;60(6):1597-603. doi: 10.1002/art.24572.

12.

Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis.

Maehlen MT, Olsen IC, Andreassen BK, Viken MK, Jiang X, Alfredsson L, Källberg H, Brynedal B, Kurreeman F, Daha N, Toes R, Zhernakova A, Gutierrez-Achury J, de Bakker PI, Martin J, Teruel M, Gonzalez-Gay MA, Rodríguez-Rodríguez L, Balsa A, Uhlig T, Kvien TK, Lie BA.

Ann Rheum Dis. 2015 Apr;74(4):762-8. doi: 10.1136/annrheumdis-2013-204173. Epub 2013 Dec 13.

PMID:
24336335
13.

Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population.

Morgan AW, Thomson W, Martin SG; Yorkshire Early Arthritis Register Consortium, Carter AM; UK Rheumatoid Arthritis Genetics Consortium, Erlich HA, Barton A, Hocking L, Reid DM, Harrison P, Wordsworth P, Steer S, Worthington J, Emery P, Wilson AG, Barrett JH.

Arthritis Rheum. 2009 Sep;60(9):2565-76. doi: 10.1002/art.24752. Erratum in: Arthritis Rheum. 2011 Mar;63(3):669. Arthritis Rheum. 2010 Oct;62(10):3005.

14.

Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.

Wagner CA, Sokolove J, Lahey LJ, Bengtsson C, Saevarsdottir S, Alfredsson L, Delanoy M, Lindstrom TM, Walker RP, Bromberg R, Chandra PE, Binder SR, Klareskog L, Robinson WH.

Ann Rheum Dis. 2015 Mar;74(3):579-86. doi: 10.1136/annrheumdis-2013-203915. Epub 2013 Dec 2.

15.

Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.

Ding B, Padyukov L, Lundström E, Seielstad M, Plenge RM, Oksenberg JR, Gregersen PK, Alfredsson L, Klareskog L.

Arthritis Rheum. 2009 Jan;60(1):30-8. doi: 10.1002/art.24135. Erratum in: Arthritis Rheum. 2009 Apr;60(4):1200.

16.

A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.

Mackie SL, Taylor JC, Martin SG; YEAR Consortium; UKRAG Consortium, Wordsworth P, Steer S, Wilson AG, Worthington J, Emery P, Barrett JH, Morgan AW.

Genes Immun. 2012 Feb;13(2):120-8. doi: 10.1038/gene.2011.60. Epub 2011 Sep 1.

PMID:
21881596
17.

HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles.

Nordang GB, Flåm ST, Maehlen MT, Kvien TK, Viken MK, Lie BA.

Rheumatology (Oxford). 2013 Nov;52(11):1973-82. doi: 10.1093/rheumatology/ket252. Epub 2013 Jul 30.

PMID:
23901134
18.

Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.

van Heemst J, Hensvold AH, Jiang X, van Steenbergen H, Klareskog L, Huizinga TW, van der Helm-van Mil A, Catrina AI, Toes RE, Lundberg K, van der Woude D.

Ann Rheum Dis. 2016 Oct;75(10):1891-8. doi: 10.1136/annrheumdis-2015-207802. Epub 2015 Dec 29.

PMID:
26715653
19.

Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study.

Mikuls TR, Gould KA, Bynoté KK, Yu F, Levan TD, Thiele GM, Michaud KD, O'Dell JR, Reimold AM, Hooker R, Caplan L, Johnson DS, Kerr G, Richards JS, Cannon GW, Criswell LA, Noble JA, Bridges SL Jr, Hughes L, Gregersen PK.

Arthritis Res Ther. 2010;12(6):R213. doi: 10.1186/ar3190. Epub 2010 Nov 18.

20.

Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.

Ronninger M, Seddighzadeh M, Eike MC, Plant D, Daha NA, Skinningsrud B, Worthington J, Kvien TK, Toes RE, Lie BA, Alfredsson L, Padyukov L.

PLoS One. 2012;7(3):e32861. doi: 10.1371/journal.pone.0032861. Epub 2012 Mar 26.

Supplemental Content

Support Center